Skip to content

Brief Internet Intervention for Hazardous Alcohol Use to People Seeking Online Help for Depression

Does Providing a Brief Internet Intervention for Hazardous Alcohol Use to People Seeking Online Help for Depression Reduce Both Alcohol Use and Depression Symptoms Among Participants With These Co-occurring Disorders? Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03421080
Enrollment
988
Registered
2018-02-05
Start date
2018-04-26
Completion date
2021-02-03
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Problem Drinking

Brief summary

Hazardous alcohol consumption is common among people suffering from depression. There are effective Internet interventions that target hazardous alcohol consumption or depression separately but none that combine these online interventions without the involvement of a therapist. This study aims to evaluate the effects of combining an Internet intervention targeting hazardous alcohol consumption with one for depression on drinking and depressive symptoms.

Detailed description

A double-blinded, parallel group randomized controlled trial will be used. Participants with current depression who also drink in a hazardous fashion (N=986) will be recruited for a study to 'help improve an online intervention for depression.' Participants will be assigned, by chance, to receive MoodGYM or to receive MoodGYM plus a brief Internet intervention for hazardous alcohol consumption - Check Your Drinking (CYD). Participants will be contacted 3- and 6-months after receiving the interventions to assess changes in drinking and depression status. It is predicted that participants receiving the CYD intervention in addition to MoodGYM will reduce their alcohol consumption to a greater extent than those who just received MoodGYM. Further predictions include the impact of receiving Check Your Drinking on improvements in depressive symptoms.

Interventions

BEHAVIORALMoodGYM

The MoodGYM Internet intervention will employ the latest version of MoodGYM (Mark 4) which has been updated to support mobile devices. The core design and function of the program has not been altered. A major focus of this intervention is to provide individuals with behavioral and cognitive strategies to improve depression symptoms.

Internet intervention designed to assess and provide feedback on hazardous alcohol use. The CYD has been subjected to seven randomized trials from two independent research groups, all of which displayed a significant impact of the CYD to reduce hazardous alcohol consumption compared to controls.

Sponsors

Centre for Addiction and Mental Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or over * score 10 or more on the Patient Health Questionnaire (PHQ-9) * score 8 or more on the Alcohol Use Disorder Identification Test (AUDIT)

Exclusion criteria

* current suicidal ideation on the PHQ-9

Design outcomes

Primary

MeasureTime frameDescription
Number of drinks in a typical week3 and 6 monthsChange in number of drinks in a typical week from baseline

Secondary

MeasureTime frameDescription
CES-D3 and 6 monthsChange in depressive symptoms using the Centre for Epidemiological Studies Depression scale (CES-D) from baseline. Total score range from zero to 60 with higher scores indicating more symptomatology.
AUDIT-C3 and 6 monthsChange in AUDIT-C score (consumption subscale from the AUDIT) from baseline
Alcohol consequences3 and 6 monthsChange in number of alcohol consequences from baseline

Other

MeasureTime frameDescription
Health related quality of life3 and 6 monthsMeasure changes in health related quality of life from baseline (EUROHIS-QoL8)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026